BR112022018637A2 - Composições e métodos para tratar e prevenir uma infecção por coronavírus - Google Patents

Composições e métodos para tratar e prevenir uma infecção por coronavírus

Info

Publication number
BR112022018637A2
BR112022018637A2 BR112022018637A BR112022018637A BR112022018637A2 BR 112022018637 A2 BR112022018637 A2 BR 112022018637A2 BR 112022018637 A BR112022018637 A BR 112022018637A BR 112022018637 A BR112022018637 A BR 112022018637A BR 112022018637 A2 BR112022018637 A2 BR 112022018637A2
Authority
BR
Brazil
Prior art keywords
coronavirus infection
subject
treat
compositions
coronavirus
Prior art date
Application number
BR112022018637A
Other languages
English (en)
Inventor
Alkalay Rachel
Original Assignee
Novel Concepts Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novel Concepts Medical Ltd filed Critical Novel Concepts Medical Ltd
Publication of BR112022018637A2 publication Critical patent/BR112022018637A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A61K36/424—Gynostemma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738—Rosa (rose)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9062—Alpinia, e.g. red ginger or galangal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/314—Foods, ingredients or supplements having a functional effect on health having an effect on lung or respiratory system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dermatology (AREA)

Abstract

COMPOSIÇÕES E MÉTODOS PARA TRATAR E PREVENIR UMA INFECÇÃO POR CORONAVÍRUS. A presente invenção refere-se a um método de prevenção ou tratamento de infecção por Coronavírus em um sujeito em necessidade do mesmo. O método compreende administrar ao sujeito uma quantidade eficaz de um componente derivado de uma espécie de planta ou gênero da mesma selecionado a partir do grupo que consiste em uma parte de planta, extrato da mesma, fração da mesma, ingrediente ativo da mesma, análogo sintético da mesma, mimético ou combinação dos mesmos, em que o componente é capaz de melhorar os sintomas da infecção por Coronavírus e em que a espécie de planta é selecionada a partir do grupo que consiste em Nigella sativa, Thymus capitatus, Thymus vulgaris, Origanum syriacum, Thymbra spicata, Satujera thymbra, Sesamum indicum e Rhus coriaria Gynostemma petaphyllum, Boswellia sacra e Panax ginseng, ou qualquer planta que contenha triptofano prevenir ou tratar o Coronavírus no sujeito.
BR112022018637A 2020-03-20 2021-03-19 Composições e métodos para tratar e prevenir uma infecção por coronavírus BR112022018637A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062992276P 2020-03-20 2020-03-20
PCT/IL2021/050307 WO2021186453A1 (en) 2020-03-20 2021-03-19 Compositions and methods for treating and preventing a coronavirus infection

Publications (1)

Publication Number Publication Date
BR112022018637A2 true BR112022018637A2 (pt) 2022-11-08

Family

ID=77768409

Family Applications (4)

Application Number Title Priority Date Filing Date
BR112022018645A BR112022018645A2 (pt) 2020-03-20 2021-03-19 Composições e métodos para tratar ou prevenir doenças inflamatórias, incluindo diabetes mellitus tipo i e tipo ii e doenças da tireoide
BR112022018639A BR112022018639A2 (pt) 2020-03-20 2021-03-19 Composições e métodos para tratar e prevenir doenças respiratórias não malignas
BR112022018649A BR112022018649A2 (pt) 2020-03-20 2021-03-19 Composições e métodos para tratar tumores sólidos e moles e doenças proliferativas
BR112022018637A BR112022018637A2 (pt) 2020-03-20 2021-03-19 Composições e métodos para tratar e prevenir uma infecção por coronavírus

Family Applications Before (3)

Application Number Title Priority Date Filing Date
BR112022018645A BR112022018645A2 (pt) 2020-03-20 2021-03-19 Composições e métodos para tratar ou prevenir doenças inflamatórias, incluindo diabetes mellitus tipo i e tipo ii e doenças da tireoide
BR112022018639A BR112022018639A2 (pt) 2020-03-20 2021-03-19 Composições e métodos para tratar e prevenir doenças respiratórias não malignas
BR112022018649A BR112022018649A2 (pt) 2020-03-20 2021-03-19 Composições e métodos para tratar tumores sólidos e moles e doenças proliferativas

Country Status (13)

Country Link
US (4) US20230346866A1 (pt)
EP (4) EP4121077A4 (pt)
JP (4) JP2023522298A (pt)
KR (4) KR20230005128A (pt)
CN (4) CN115666540A (pt)
AU (4) AU2021239186A1 (pt)
BR (4) BR112022018645A2 (pt)
CA (4) CA3175442A1 (pt)
CO (4) CO2022013172A2 (pt)
IL (4) IL296407A (pt)
MX (4) MX2022011572A (pt)
WO (4) WO2021186456A1 (pt)
ZA (4) ZA202210080B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102445444B1 (ko) * 2021-12-09 2022-09-22 주식회사 나투어바이오제약 안전성을 기반으로 한 고함량의 기능성 성분을 포함하는 발효흑삼 제조 개선 방법
CN115651088A (zh) * 2022-08-23 2023-01-31 辽宁成大生物股份有限公司 人参总多糖的制备方法和应用、人参总多糖疫苗佐剂及其疫苗组合物
CN116036262A (zh) * 2022-08-23 2023-05-02 沈阳药科大学 一种人参酸性多糖疫苗佐剂、疫苗组合物及其应用
CN115501333A (zh) * 2022-09-27 2022-12-23 沈阳药科大学 一种疫苗佐剂、疫苗组合物及其应用
CN117462539A (zh) * 2023-12-26 2024-01-30 云南中医药大学 一种二氢黄酮醇型化合物的抗冠状病毒用途及制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1054514C (zh) * 1992-05-11 2000-07-19 卜荣安 绞股兰复合保健茶的制作工艺
JP4651756B2 (ja) * 1997-02-25 2011-03-16 サランティス プロプライエタリィ リミテッド ブロメラインの成分である単離されたタンパク質、同タンパク質を含む治療剤及び製薬組成物
US9072753B1 (en) * 2000-04-03 2015-07-07 Amy C. Brown Gargle method to reduce the duration of common cold symptoms
WO2002080951A1 (en) * 2001-04-06 2002-10-17 Synergistix Biotech, Inc. Herbal extracts for the treatment of cancer
US8029831B2 (en) * 2008-07-29 2011-10-04 Bionexus, Ltd. Formulations containing thymoquinone for urinary health
CA2626049A1 (en) * 2004-10-15 2006-04-20 Biopharmacopae Design International Inc. Methods and therapeutic compositions comprising plant extracts for the treatment of cancer
CN101227916A (zh) * 2005-05-24 2008-07-23 维尔金有限公司 预防和治疗发炎相关状况的组合物和方法
US20080038367A1 (en) * 2006-08-11 2008-02-14 Sal Saloum Nutritional supplement compositions and methods of preparing
US20110086052A1 (en) * 2008-02-29 2011-04-14 Adamko Darryl J Activation of innate and adaptive immune responses by a ginseng extract
CN102264364B (zh) * 2008-10-22 2014-06-18 康奈尔大学 一种多环化合物及其相关方法
US20100119558A1 (en) * 2008-11-10 2010-05-13 Scandivir Ab Ngna compositions and methods of use
GB0917086D0 (en) * 2009-09-29 2009-11-11 Union Of Agricultural Cooperat Compositon of botanical extracts and their use
US8734859B1 (en) * 2010-11-13 2014-05-27 Sirbal Ltd. Molecular combinations for cancer or other disease treatment
US20130344215A1 (en) * 2012-06-26 2013-12-26 Yl Holdings, Inc. Weight loss beverage
WO2016014699A1 (en) * 2014-07-22 2016-01-28 Ralco Nutrition, Inc. Antiviral compositions and methods
WO2016051220A1 (en) * 2014-09-30 2016-04-07 Umm Al-Qura University Parsley (petroselinum crispum) as a remedy for diabetes mellitus
CA2986449C (en) * 2015-05-19 2021-11-23 Ralco Nutrition, Inc. Essential oil compositions and applications utilizing essential oils
CN106805055A (zh) * 2015-11-27 2017-06-09 殷志杰 一种具有抗癌作用的养生饮品
US20200246449A1 (en) * 2017-05-03 2020-08-06 Nanobio Corporation Intravenous immunoglobulin compositions specific for respiratory syncytial virus and methods of making and using the same
IL257224B (en) * 2018-01-29 2020-01-30 Kim Sawdayee Compounds and methods for treating hair and scalp
EP3843765A4 (en) * 2018-08-27 2022-06-01 Emerald Health Therapeutics Canada Inc. THERAPEUTIC COMBINATIONS OF BOSWELLIA EXTRACT AND CANNABINOIDS
US20200397711A1 (en) * 2019-06-22 2020-12-24 Gregory Brian LEE Microparticle compositions for treatment of infection or disease, methods of making the same, and methods of treating subjects with microparticle compositions
WO2021183995A1 (en) * 2020-03-13 2021-09-16 Furst-Mcness Company Compositions and methods for prevention and treatment of viral disorders

Also Published As

Publication number Publication date
EP4121021A1 (en) 2023-01-25
MX2022011517A (es) 2023-01-04
CA3175444A1 (en) 2021-09-23
WO2021186453A1 (en) 2021-09-23
IL296398A (en) 2022-11-01
KR20230005128A (ko) 2023-01-09
US20230346866A1 (en) 2023-11-02
WO2021186455A1 (en) 2021-09-23
ZA202210076B (en) 2024-01-31
US20230134432A1 (en) 2023-05-04
JP2023526724A (ja) 2023-06-23
ZA202210080B (en) 2024-01-31
EP4121077A4 (en) 2024-06-19
BR112022018645A2 (pt) 2022-11-08
CO2022013171A2 (es) 2022-11-29
WO2021186456A1 (en) 2021-09-23
ZA202210078B (en) 2024-01-31
AU2021239186A1 (en) 2022-10-13
AU2021236988A1 (en) 2022-10-13
CA3175440A1 (en) 2021-09-23
EP4121019A1 (en) 2023-01-25
WO2021186454A1 (en) 2021-09-23
CN116096360A (zh) 2023-05-09
MX2022011535A (es) 2023-01-04
MX2022011572A (es) 2023-01-04
IL296399A (en) 2022-11-01
EP4121022A4 (en) 2024-06-19
KR20230005130A (ko) 2023-01-09
KR20230005131A (ko) 2023-01-09
JP2023522299A (ja) 2023-05-30
KR20230005129A (ko) 2023-01-09
CN115666540A (zh) 2023-01-31
JP2023522297A (ja) 2023-05-30
US20240226218A1 (en) 2024-07-11
EP4121019A4 (en) 2024-04-24
CN116056690A (zh) 2023-05-02
CO2022013172A2 (es) 2022-11-29
IL296407A (en) 2022-11-01
EP4121022A1 (en) 2023-01-25
AU2021237876A1 (en) 2022-10-13
CO2022013167A2 (es) 2023-01-26
MX2022011573A (es) 2023-01-04
US20230181665A1 (en) 2023-06-15
BR112022018649A2 (pt) 2022-11-01
ZA202210079B (en) 2024-01-31
CA3175446A1 (en) 2021-09-23
BR112022018639A2 (pt) 2022-11-08
CA3175442A1 (en) 2021-09-23
JP2023522298A (ja) 2023-05-30
CO2022013166A2 (es) 2022-11-18
EP4121077A1 (en) 2023-01-25
EP4121021A4 (en) 2024-06-19
IL296402A (en) 2022-11-01
CN116075314A (zh) 2023-05-05
AU2021239187A1 (en) 2022-10-13

Similar Documents

Publication Publication Date Title
BR112022018637A2 (pt) Composições e métodos para tratar e prevenir uma infecção por coronavírus
Baradaran et al. A review study on medicinal plants affecting amnesia through cholinergic system
Shanmugam et al. Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats
Essa et al. Review of natural products on Parkinson’s disease pathology
Chethana et al. Cassia tora Linn.: A boon to Alzheimer's disease for its anti-amyloidogenic and cholinergic activities
Rabiei Anticonvulsant effects of medicinal plants with emphasis on mechanisms of action
Krishnan et al. Effect of Nigella sativa seed extract on carbon tetrachloride-induced hepatotoxicity in rats
Bhatia et al. Bacopa monnieri extracts prevent hydrogen peroxide-induced oxidative damage in a cellular model of neuroblastoma IMR32 cells
Akbari et al. Protective effects of Sanguisorba minor and Ferulago angulata total extracts against beta-amyloid induced cytotoxicity and oxidative stress in cultured cerebellar granule neurons
Avneet et al. A review on herbal Ayurvedic medicinal plants and its association with memory functions
Neta et al. Effects of Mucuna pruriens (L.) supplementation on experimental models of Parkinson's disease: a systematic review
Lalotra et al. Scientific reports of medicinal plants used for the prevention and treatment of neurodegenerative diseases
Kim et al. Annona muricata leaf extract attenuates hepatic lipogenesis and adipogenesis
Swathi et al. Protective role of Bacopa monnieri on induced Parkinson’s disease with particular reference to catecholamine system
Oghenevwodoko Okoro et al. Anti-oxidant and hepatoprotective effects of senecio biafrae on CCl4-induced liver damage in rats
Ahmed FICUS benghalensis bark extract shows blood pressure lowering effect in normotensive and angiotensin ii-induced hypertensive rats
Awathale et al. Neuroactive herbal agents for cognitive dysfunction
Gholizadeh et al. The effect of oral administration of eggplant hydroalcoholic extract on avoidance memory retrieval in streptozotocin-induced diabetic male rats
Mostafapour et al. Anxiolytic and antidepressant effects of Basil (Ocimum basilicum L.) hydro-alcoholic extract in male rats exposed to chronic restraint stress
Visweswari et al. Withania somnifera against glutamate excitotoxicity and neuronal cell loss in a scopolamine-induced rat model of Alzheimer’s disease
Orhue et al. Ethanol extract of Dacryodes edulis seeds suppresses carbon tetrachloride-induced liver damage in Wistar albino rats
Dwivedi et al. Indopathy for Neuroprotection in Parkinson’s
Cho et al. Neuroprotective and antioxidant effects of the butanol fraction prepared from Opuntia ficus-indica var. saboten
Hamid et al. Cardioprotective and antilipidemic effect of gemmotherapeutically treated Glycyrrhiza glabra against isoproterenol induced myocardial injury
Yeong et al. Neuroprotection with the Functional Herbs from the Lamiaceae Family

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]